THOMAS JOHN RIPPERDA M.D.
Prescription History 1720054091
Physical Medicine & Rehabilitation in Sioux Falls, SD

NPI Status: Active since February 27, 2006

Contact Information

1301 S. CLIFF AVE
STE 401
SIOUX FALLS, SD
ZIP 57105
Phone: (605) 322-7300
Fax: (605) 322-7301

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for THOMAS JOHN RIPPERDA M.D., an active Physical Medicine & Rehabilitation specialist practicing in Sioux Falls, SD. Our medical registry currently tracks 22 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,099 documented patient claims. Among these therapy options, the most frequently utilized medication is Pregabalin, which accounts for 189 claims alone.


Amitriptyline Hcl

Generic Formulation: Amitriptyline HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 35
30-Day Fills 38.0
Days Supply 1,140
SD State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills48.3
Peer Average Days Supply1,425
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 29.6% more claims than the standard regional baseline profile for SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $324.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.27

State Avg Cost Per Claim

$19.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat mental/mood problems such as depression. It may help improve mood and feelings of well-being, relieve anxiety and tension, help you sleep better, and increase your energy level. This medication belongs to a class of medications called tricyclic antidepressants. It works by affecting the balance of certain natural chemicals (neurotransmitters such as serotonin) in the brain.

Baclofen

Generic Formulation: BaclofenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 89
30-Day Fills 98.0
Days Supply 2,631
SD State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills38.1
Peer Average Days Supply1,026
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 187.1% higher than the standard regional baseline profile for SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,002.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.50

State Avg Cost Per Claim

$27.31

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Buprenorphine

Generic Formulation: BuprenorphineSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 392
SD State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills42.3
Peer Average Days Supply1,168
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 66.7% less volume than the regional standard for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,124.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$437.45

State Avg Cost Per Claim

$328.93

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.

Therapeutic Applications

This medication is used to help relieve severe ongoing pain (such as due to arthritis, chronic back pain). Buprenorphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. The higher strengths of this drug (7.5, 10, 15, or 20 micrograms per hour patches) should be used only if you have been regularly taking moderate amounts of opioid pain medication. These strengths may cause overdose (even death) if used by a person who has not been regularly taking opioids. Do not use this medication to relieve pain that is mild or that will go away in a few days. This medication is not for occasional (as needed) use.

Cyclobenzaprine Hcl

Generic Formulation: Cyclobenzaprine HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 23
30-Day Fills 26.0
Days Supply 700
SD State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills33.9
Peer Average Days Supply811
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $471.23 across this reporting matrix range.

Provider Avg Cost Per Claim

$20.49

State Avg Cost Per Claim

$14.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Cyclobenzaprine is used short-term to treat muscle spasms. It is usually used along with rest and physical therapy. It works by helping to relax the muscles. This medication is not recommended for use in older adults because they may be at greater risk for side effects while using this drug. Ask the doctor or pharmacist for details.

Diclofenac Sodium

Generic Formulation: Diclofenac SodiumSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 136
SD State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills36.9
Peer Average Days Supply761
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.8% less volume than the regional standard for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $577.59 across this reporting matrix range.

Provider Avg Cost Per Claim

$41.26

State Avg Cost Per Claim

$25.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Therapeutic Applications

See also Warning section. This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain.

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 107
30-Day Fills 139.4
Days Supply 4,137
SD State Average Benchmarks
Peer Average Claims50.0
Peer Average 30-Day Fills83.8
Peer Average Days Supply2,415
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 114.0% higher than the standard regional baseline profile for SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,596.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.92

State Avg Cost Per Claim

$36.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Gabapentin

Generic Formulation: GabapentinSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 164
30-Day Fills 207.8
Days Supply 6,053
SD State Average Benchmarks
Peer Average Claims75.0
Peer Average 30-Day Fills112.1
Peer Average Days Supply3,224
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 118.7% higher than the standard regional baseline profile for SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,635.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.17

State Avg Cost Per Claim

$19.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Hydrocodone-Acetaminophen

Generic Formulation: Hydrocodone/AcetaminophenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 54
30-Day Fills 54.0
Days Supply 1,048
SD State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills52.5
Peer Average Days Supply858
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,204.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.30

State Avg Cost Per Claim

$19.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to relieve moderate to severe pain. It contains an opioid pain reliever (hydrocodone) and a non-opioid pain reliever (acetaminophen). Hydrocodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Levetiracetam

Generic Formulation: LevetiracetamSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 18
30-Day Fills 20.0
Days Supply 561
SD State Average Benchmarks
Peer Average Claims46.0
Peer Average 30-Day Fills62.2
Peer Average Days Supply1,746
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.9% less volume than the regional standard for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $255.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.20

State Avg Cost Per Claim

$35.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolidinone and acetamide derivative that is used primarily for the treatment of SEIZURES and some movement disorders, and as a nootropic agent.

Therapeutic Applications

Levetiracetam is used to treat seizures (epilepsy). It belongs to a class of drugs known as anticonvulsants. Levetiracetam may decrease the number of seizures you have.

Meloxicam

Generic Formulation: MeloxicamSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 678
SD State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills71.3
Peer Average Days Supply2,074
Conservative Utilization

This provider writes prescriptions for this formulation 44.2% less frequently than the standard regional baseline metric for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $87.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$3.67

State Avg Cost Per Claim

$5.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzothiazine and thiazole derivative that acts as a NSAID and cyclooxygenase-2 (COX-2) inhibitor. It is used in the treatment of RHEUMATOID ARTHRITIS; OSTEOARTHRITIS; and ANKYLOSING SPONDYLITIS.

Therapeutic Applications

Meloxicam is used to help relieve moderate to severe pain. Meloxicam is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling or pain.

Methocarbamol

Generic Formulation: MethocarbamolSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 30
30-Day Fills 30.4
Days Supply 567
SD State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills21.3
Peer Average Days Supply516
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 57.9% higher than the standard regional baseline profile for SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $322.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.74

State Avg Cost Per Claim

$13.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A centrally acting muscle relaxant whose mode of action has not been established. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1206)

Therapeutic Applications

Methocarbamol is used to treat muscle spasms/pain. It is usually used along with rest, physical therapy, and other treatment. It works by helping to relax the muscles.

Methylprednisolone

Generic Formulation: MethylprednisoloneSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 14
30-Day Fills 14.0
Days Supply 82
SD State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills24.9
Peer Average Days Supply171
Conservative Utilization

This provider writes prescriptions for this formulation 41.7% less frequently than the standard regional baseline metric for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $134.98 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.64

State Avg Cost Per Claim

$11.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A PREDNISOLONE derivative with similar anti-inflammatory action.

Therapeutic Applications

Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.

Morphine Sulfate

Generic Formulation: Morphine SulfateSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 33
30-Day Fills 33.0
Days Supply 756
SD State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills22.0
Peer Average Days Supply441
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 57.1% higher than the standard regional baseline profile for SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,428.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$43.28

State Avg Cost Per Claim

$29.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Therapeutic Applications

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Morphine Sulfate Er

Generic Formulation: Morphine SulfateSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 29
30-Day Fills 29.0
Days Supply 837
SD State Average Benchmarks
Peer Average Claims52.0
Peer Average 30-Day Fills52.9
Peer Average Days Supply1,449
Conservative Utilization

This provider writes prescriptions for this formulation 44.2% less frequently than the standard regional baseline metric for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $651.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.46

State Avg Cost Per Claim

$35.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.

Therapeutic Applications

This medication is used to treat severe pain. Morphine belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Nucynta

Generic Formulation: Tapentadol HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 68
30-Day Fills 68.0
Days Supply 345
SD State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills21.1
Peer Average Days Supply413
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 223.8% higher than the standard regional baseline profile for SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $19,120.80 across this reporting matrix range.

Provider Avg Cost Per Claim

$281.19

State Avg Cost Per Claim

$677.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An opioid analgesic, MU OPIOID RECEPTOR agonist, and noradrenaline reuptake inhibitor that is used in the treatment of moderate to severe pain, and of pain associated with DIABETIC NEUROPATHIES.

Therapeutic Applications

Tapentadol is used to help relieve moderate to severe short-term pain (such as pain from an injury or after surgery). It belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Oxycodone Hcl

Generic Formulation: Oxycodone HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 25
30-Day Fills 25.0
Days Supply 296
SD State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills38.8
Peer Average Days Supply581
Conservative Utilization

This provider writes prescriptions for this formulation 34.2% less frequently than the standard regional baseline metric for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $236.68 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.47

State Avg Cost Per Claim

$15.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semisynthetic derivative of CODEINE.

Therapeutic Applications

This medication is used to help relieve moderate to severe pain. Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Oxycodone-Acetaminophen

Generic Formulation: Oxycodone Hcl/AcetaminophenSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 26
30-Day Fills 26.0
Days Supply 492
SD State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills38.3
Peer Average Days Supply768
Conservative Utilization

This provider writes prescriptions for this formulation 31.6% less frequently than the standard regional baseline metric for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,469.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$56.51

State Avg Cost Per Claim

$22.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to help relieve moderate to severe pain. It contains an opioid pain reliever (oxycodone) and a non-opioid pain reliever (acetaminophen). Oxycodone works in the brain to change how your body feels and responds to pain. Acetaminophen can also reduce a fever.

Prednisone

Generic Formulation: PrednisoneSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 22
30-Day Fills 22.0
Days Supply 128
SD State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills50.6
Peer Average Days Supply930
Conservative Utilization

This provider writes prescriptions for this formulation 46.3% less frequently than the standard regional baseline metric for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $42.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$1.95

State Avg Cost Per Claim

$5.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.

Therapeutic Applications

Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.

Pregabalin

Generic Formulation: PregabalinSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 189
30-Day Fills 216.1
Days Supply 6,367
SD State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills44.3
Peer Average Days Supply1,272
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 440.0% higher than the standard regional baseline profile for SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,213.93 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.88

State Avg Cost Per Claim

$44.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Ropinirole Hcl

Generic Formulation: Ropinirole HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
SD State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills44.1
Peer Average Days Supply1,272
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.9% less volume than the regional standard for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $751.55 across this reporting matrix range.

Provider Avg Cost Per Claim

$57.81

State Avg Cost Per Claim

$19.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used alone or with other medications to treat Parkinson's disease. It can improve your ability to move and decrease shakiness (tremor), stiffness, slowed movement, and unsteadiness. It may also decrease the number of episodes of not being able to move (on-off syndrome). Ropinirole works by helping to restore the balance of a certain natural substance (dopamine) in the brain.

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 77
30-Day Fills 77.2
Days Supply 2,206
SD State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills35.8
Peer Average Days Supply910
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 156.7% higher than the standard regional baseline profile for SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,816.67 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.59

State Avg Cost Per Claim

$14.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Tramadol Hcl

Generic Formulation: Tramadol HclSpecialty: Physical Medicine and Rehabilitation
Provider Metrics Summary
Total Claims 31
30-Day Fills 31.0
Days Supply 508
SD State Average Benchmarks
Peer Average Claims54.0
Peer Average 30-Day Fills55.7
Peer Average Days Supply998
Conservative Utilization

This provider writes prescriptions for this formulation 42.6% less frequently than the standard regional baseline metric for practitioners inside SD. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $288.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.32

State Avg Cost Per Claim

$6.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A narcotic analgesic proposed for severe pain. It may be habituating.

Therapeutic Applications

See also Warning section. This medication is used to help relieve moderate to moderately severe pain. Tramadol belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like THOMAS JOHN RIPPERDA M.D. provides transparency into local medical care patterns within Sioux Falls, SD.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Physical Medicine & Rehabilitation** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.